GlassScriptPhysician profile
Amy Perry
NPI 1760485957
$1,348.30
in general payments reported to CMS, 2019-2025
12 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $233 · 2024: $774 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,348.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $402.25 | 2023-2025 | Veltassa, Korsuva |
| Boston Scientific Corporation | $174.08 | 2024 | Watchman Flx |
| Bayer Healthcare Pharmaceuticals INC. | $139.45 | 2024 | |
| Outset Medical INC | $126.52 | 2025 | |
| Cormedix INC. | $104.21 | 2025 | Defencath |
| Calliditas Therapeutics US INC. | $103.64 | 2024 | |
| Nxstage Medical, INC. | $98.60 | 2023 | Nxstage System One |
| Ardelyx, INC. | $69.66 | 2024 | Xphozah 30 Mg |
| Novartis Pharmaceuticals Corporation | $60.25 | 2025 | |
| Glaxosmithkline, LLC. | $42.38 | 2024 | |
| Atricure, INC. | $16.32 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.94 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.